首页> 美国卫生研究院文献>JAK-STAT >Lentiginoses in polycythemia vera patient: Is there a role for JAK2 (V617F) mutation?
【2h】

Lentiginoses in polycythemia vera patient: Is there a role for JAK2 (V617F) mutation?

机译:真性红细胞增多症患者的豆荚菌病:JAK2(V617F)突变是否起作用?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lentiginoses is a clinical feature in which lentigines are remarkably present in large numbers or when they occur in a distinctive distribution on apparently normal skin. This entity may be congenital or acquired and may cover a wide spectrum of diseases ranging from an isolated benign pigmentary disorder to numerous syndromes associated with molecular abnormalities.We present a 59-year-old female patient with multiple lentigines which first emerged 3 y ago concurrently with policytemia vera. The patient had found to be positive for Janus Kinase-2 (JAK-2) mutation. Over activation of the pathway due to JAK-2 V617F mutation is a well-known condition in myeloproliferative diseases but has not been reported in melanocytic disorders. Moreover, several signaling pathways have previously been defined with lentiginosis except JAK-STAT pathway. We want to draw attention to the potential effect of JAK-2 mutation in lentigogenesis with this case report.
机译:豆荚菌素酶是一种临床特征,其中大量存在或在明显正常的皮肤上以独特的分布形式出现时,会产生大量的龙胆素。该实体可能是先天性的,也可能是后天性的,并且可能涵盖从孤立的良性色素性疾病到与分子异常有关的多种综合症等多种疾病。我们介绍了一位59岁的女性患者,该患者有多种扁桃体素,并在3年​​前首次出现与政策性维拉。该患者发现Janus Kinase-2(JAK-2)突变呈阳性。由于JAK-2 V617F突变而导致的通路过度活化是骨髓增生性疾病中的一种众所周知的病状,但尚未在黑素细胞病中报道。此外,除JAK-STAT途径外,以前已确定了几种与慢病有关的信号传导途径。我们想提请注意此病例报告中JAK-2突变在迟发型形成中的潜在作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号